PharmaChange
2.1K views | +0 today
Follow
PharmaChange
On the way to the modern pharma - all about change & innovation in pharma industry
Your new post is loading...
Your new post is loading...
Scooped by Aleksandra Misiorowska
Scoop.it!

Pharma M&A: Agile shouldn’t mean ad hoc | McKinsey & Company

Pharma M&A: Agile shouldn’t mean ad hoc | McKinsey & Company | PharmaChange | Scoop.it
Under pressure to be active acquirers, some pharmaceutical and medical-products companies may be neglecting best practices. Here’s where they can most improve.
more...
No comment yet.
Scooped by Aleksandra Misiorowska
Scoop.it!

Meet Pharma’s Biggest Innovators | Thought leadership and innovation for the Pharmaceutical Industry - EyeforPharma

Meet Pharma’s Biggest Innovators | Thought leadership and innovation for the Pharmaceutical Industry - EyeforPharma | PharmaChange | Scoop.it
With projects submitted from Scotland to Togo, the 2016 eyeforpharma Barcelona Awards pulled in a diverse range of incredible projects.
more...
No comment yet.
Scooped by Aleksandra Misiorowska
Scoop.it!

Digitization of Pharmaceutical Industry – Accenture

Digitization of Pharmaceutical Industry – Accenture | PharmaChange | Scoop.it
Digitize partially—to buy some time Many companies, if not most, are already doing this. They are digitizing key parts of their value chains—and the customer experience in particular. But with so many mainstream players implementing similar initiatives, the advantages partial digitization delivers will soon be commoditized. Partial digitization can and should be used as a learning curve—but remaining relevant for the longer term will require additional, more radical measures. To win—combine partial digitization with building new business models Our analysis shows that only digital all-rounders can hope to become proactive digital leaders. They achieve this by combining partial digitization with building new business models that address new markets. To become a digital all-rounder, companies need to: Provide clear guidance from the top. Digital is here to stay. It needs the same top management attention as any other strategic initiative. Installing a chief digital officer is not sufficient. Every executive needs to make digital a priority and act as an obstacle solver. Address the market as a whole. Seek to create value for the entire health ecosystem—from prevention and care in core markets, to offerings for others. Consider, for example, how Merck’s spin-off Vree Health helps healthcare organizations meet patient engagement, accountable-care and care coordination goals. Look for market growth. If you target the right markets, profitability will be your reward. But think disruptively. Make a completely new attempt to drive success, even if you don’t yet have the performance metrics to prove its worth. Learn, share and partner to create new business opportunities. With the right partner you will develop a wider value orientation. Pfizer, for example, has hooked up with the startup, Akili Interactive Labs, in a clinical trial to evaluate whether or not a video game can be used to predict Alzheimer’s disease. Foster a digital culture and mind-set and build required skills. Sales experience, not digital experience, currently sets the agenda for most pharmaceutical players. That needs to change. So find ways of making life sciences attractive to talent with proven digital skills—the kind of talent behind Google, Twitter, Facebook and Netflix. For more information, download: ALL TO WIN OR ALL TO LOSE: DRIVING DIGITIZATION IN LIFE SCIENCES
more...
No comment yet.
Scooped by Aleksandra Misiorowska
Scoop.it!

Creating Patient-Centric Growth | Thought leadership and innovation for the Pharmaceutical Industry - EyeforPharma

Creating Patient-Centric Growth | Thought leadership and innovation for the Pharmaceutical Industry - EyeforPharma | PharmaChange | Scoop.it
So, how exactly does a pharma company create patient-centric growth? Jill Donahue, who is an industry speaker and co-creator of the award-winning program EngageRx, describes this as the million dollar question that pharma companies ask. Donahue has spent her entire career, both inside pharma and now from the outside, advocating that growth through patient centricity is key to pharma’s future.
more...
No comment yet.
Scooped by Aleksandra Misiorowska
Scoop.it!

The Shift to Patients | Thought leadership and innovation for the Pharmaceutical Industry - EyeforPharma

The Shift to Patients | Thought leadership and innovation for the Pharmaceutical Industry - EyeforPharma | PharmaChange | Scoop.it
As patients gain access to increasing amounts of high-quality health data online, their interaction with doctors – and with pharma itself – is changing. Kasper Jerlang, Head, Global Patient Communications at LEO Pharma is excited about the opportunities this offers. “If we want to help patients, we need to shift some of our focus to providing information when they need it and where they look for it,” he says.
more...
No comment yet.
Scooped by Aleksandra Misiorowska
Scoop.it!

Celebrating Biopharma Innovation: The Top 10 | Thought leadership and innovation for the Pharmaceutical Industry - EyeforPharma

Celebrating Biopharma Innovation: The Top 10 | Thought leadership and innovation for the Pharmaceutical Industry - EyeforPharma | PharmaChange | Scoop.it
As highlighted in ‘The Future of Pharma: Innovation,’ pharmaceutical and biotech leaders were to join IDEA Pharma in launching the first in a series of panel discussion sessions, called "The Future of Pharma." These discussions took place on the evening of January 11th 2016, at the annual J. P. Morgan Healthcare Conference, San Francisco. We spoke to IDEA Pharma CEO, Mike Rea, to find out how the event went.
more...
No comment yet.
Scooped by Aleksandra Misiorowska
Scoop.it!

Six predictions for pharma and digital health in 2016 – DRG Blog – DRG

Six predictions for pharma and digital health in 2016 – DRG Blog – DRG | PharmaChange | Scoop.it
What will 2016 bring for pharma? Well, the cognoscenti are in consensus that there will be more ugly wrangling over drug prices, but beyond that media...
more...
No comment yet.
Scooped by Aleksandra Misiorowska
Scoop.it!

Biosimilars Are Coming After Big Pharma's Bottom Line

Biosimilars Are Coming After Big Pharma's Bottom Line | PharmaChange | Scoop.it
The coming wave of biosimilars, which are generic versions of biologic drugs, will take sales away from big pharmaceutical companies.
more...
No comment yet.
Scooped by Aleksandra Misiorowska
Scoop.it!

Measuring the return from pharmaceutical innovation 2015 | Deloitte US | Life Sciences and Healthcare

Our sixth annual pharmaceutical innovation study looks at the challenges the industry faces in generating returns from its R&D investments, while highlighting lessons that can be learned.
more...
No comment yet.
Scooped by Aleksandra Misiorowska
Scoop.it!

Norvatis - Our Business Model Banks On Govts Creating Demand for $1 Therapy Drug - AllAfrica.com

Novartis Pharma recently launched the Novartis Access portfolio in Kenya. The president and head of Africa cluster spoke with Elizabeth Merab about the deal and why two East African countries were chosen as beneficiaries.
more...
No comment yet.
Scooped by Aleksandra Misiorowska
Scoop.it!

The bad boys of pharma: Investors love them — until cracks in the model appear - Financial Post

The bad boys of pharma: Investors love them — until cracks in the model appear - Financial Post | PharmaChange | Scoop.it
Allegations of fraudulent sales related to Valeant's ownership of specialty pharmacies are shedding light on how the strange economics of the American pharmaceutical industry created opportunities for gaming the system...
more...
No comment yet.
Scooped by Aleksandra Misiorowska
Scoop.it!

Big pharma won't stay silent in drug pricing debate for long - Fortune

Big pharma won't stay silent in drug pricing debate for long - Fortune | PharmaChange | Scoop.it
Industry preparing its defense of sky-high costs
more...
No comment yet.
Scooped by Aleksandra Misiorowska
Scoop.it!

A Boehringer SVP and BioSig's CEO dish on the 'heart' of innovation - BioPharma Dive

A Boehringer SVP and BioSig's CEO dish on the 'heart' of innovation - BioPharma Dive | PharmaChange | Scoop.it
BioPharma Dive spoke with Dr. Sabine Luik, Senior Vice President of Medicine & Regulatory Affairs at Boehringer Ingelheim and Greg Cash, CEO of BioSig Technologies, about different strategies for reducing the risk of stroke in patients with atrial...
more...
No comment yet.
Scooped by Aleksandra Misiorowska
Scoop.it!

Singapore: A Main Driver in Research and Development for Pharmaceuticals

Singapore: A Main Driver in Research and Development for Pharmaceuticals | PharmaChange | Scoop.it
Singapore is the world 12th largest pharmaceuticals producer, and over 30 drug producers have a research and development presence in Singapore
more...
No comment yet.
Scooped by Aleksandra Misiorowska
Scoop.it!

Six predictions for pharma and digital health in 2016 – Digital Innovation – DRG

Six predictions for pharma and digital health in 2016 – Digital Innovation – DRG | PharmaChange | Scoop.it
What will 2016 bring for pharma? Well, the cognoscenti are in consensus that there will be more ugly wrangling over drug prices, but beyond that media...
more...
No comment yet.
Scooped by Aleksandra Misiorowska
Scoop.it!

The Startup Tracking ‘Valuable’ Doctors for Big Pharma

The Startup Tracking ‘Valuable’ Doctors for Big Pharma | PharmaChange | Scoop.it
Zephyr Health says it can determine the value of a doctor’s prescription pad.
more...
No comment yet.
Scooped by Aleksandra Misiorowska
Scoop.it!

Partnerships in Pharma | Novartis Pharmaceuticals

Partnerships in Pharma | Novartis Pharmaceuticals | PharmaChange | Scoop.it
February 10, 2016 The Novartis Pharmaceuticals Business Development and Licensing team enables the partnerships that make innovating for patients possible.
more...
No comment yet.
Scooped by Aleksandra Misiorowska
Scoop.it!

Big Pharma's bet on Big Data creates opportunities and risks

Big Pharma's bet on Big Data creates opportunities and risks | PharmaChange | Scoop.it
Novartis wants every puff of its emphysema drug Onbrez to go into the cloud.
more...
No comment yet.
Scooped by Aleksandra Misiorowska
Scoop.it!

Is Pharma Taking the Wrong Approach to PatientCentricity

Is Pharma Taking the Wrong Approach to PatientCentricity | PharmaChange | Scoop.it
Life-sciences companies often behave as though focusing on patient needs is simply a matter of asking, “How can we provide patients with more services?”

P
more...
No comment yet.
Scooped by Aleksandra Misiorowska
Scoop.it!

How pharma can stay competitive in the digital world

How pharma can stay competitive in the digital world | PharmaChange | Scoop.it
Drugmakers seeking to develop "beyond-the-pill" digital initiatives have to be willing to engage patients in new ways, McKinsey & Company report finds.
more...
No comment yet.
Scooped by Aleksandra Misiorowska
Scoop.it!

Is Pharma Ready for the Future?

Is Pharma Ready for the Future? | PharmaChange | Scoop.it
The way medicine is manufactured is about to be radically transformed.
more...
No comment yet.
Scooped by Aleksandra Misiorowska
Scoop.it!

Has the era of the super successful pharma sales rep really come to an end? - BioPharma Dive

Has the era of the super successful pharma sales rep really come to an end? - BioPharma Dive | PharmaChange | Scoop.it
We spoke with James Crowley, author of the Accenture report “The Rebirth of the Pharmaceutical Sales Force,” to gain insights into why some pharma sales reps are actually doing better than ever.
more...
No comment yet.
Scooped by Aleksandra Misiorowska
Scoop.it!

A Prescription to Cure Big Pharma's Image Problem - Pharmaceutical Processing

A Prescription to Cure Big Pharma's Image Problem - Pharmaceutical Processing | PharmaChange | Scoop.it
Drug companies need to rethink their marketing strategies, says a Concordia professor in her new book.
more...
No comment yet.
Scooped by Aleksandra Misiorowska
Scoop.it!

Strategic planning in pharma and avoiding frog soup - PMLiVE

Strategic planning in pharma and avoiding frog soup - PMLiVE | PharmaChange | Scoop.it
PMLiVE Strategic planning in pharma and avoiding frog soup PMLiVE In an environment where society, healthcare and global communications are evolving in significant but subtle ways, the development of strategic plans that pre-empt change is the only...
more...
No comment yet.